{"DataElement":{"publicId":"5543179","version":"1","preferredName":"Ductal Breast Carcinoma In Situ Histology Classification Grade Code","preferredDefinition":"Records the degree of dysplasia for the cyst or Ductal carcinoma in situ (DCIS) lesion under consideration.","longName":"2678758v1.0:5542895v1.0","context":"EDRN","contextVersion":"1","DataElementConcept":{"publicId":"2678758","version":"1","preferredName":"Ductal Breast Carcinoma In Situ Histology Classification","preferredDefinition":"information related to the systematic arrangement of the cells and constitute tissues of Ductal carcinoma in situ (DCIS), a carcinoma entirely confined to the mammary ducts, by classes or groups.","longName":"DCIS_HIST_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2413053","version":"1","preferredName":"DCIS","preferredDefinition":"Ductal carcinoma in situ (DCIS) is a carcinoma entirely confined to the mammary ducts.  There is no evidence of invasion of the basement membrane.  Currently, DCIS is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS. --2002","longName":"C2924","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"01D4D496-BCED-3A9F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-30","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-09-30","modifiedBy":"ONEDATA","dateModified":"2005-09-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2433874","version":"1","preferredName":"Histology Classification","preferredDefinition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.:Classification; the grouping of things into classes or categories.","longName":"C16681:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"062E16DD-4D12-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"398CF522-8C9C-31C5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-07","modifiedBy":"UMLLDR","dateModified":"2016-10-25","changeDescription":"Update to use OC DCIS with concept name dw 05-13-2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5542895","version":"1","preferredName":"Neoplasm Histologic Grade Code","preferredDefinition":"Records the degree of dysplasia for the cyst or lesion under consideration.","longName":"5542895v1.0","context":"EDRN","contextVersion":"1","type":"Enumerated","dataType":"NUMBER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"99","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"47DDB57A-66EE-08C0-E053-F662850AC0C1","beginDate":"2017-02-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-06","modifiedBy":"ONEDATA","dateModified":"2017-02-06","deletedIndicator":"No"},{"value":"3","valueDescription":"High Grade","ValueMeaning":{"publicId":"3288211","version":"1","preferredName":"High Grade","longName":"3288211","preferredDefinition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade","conceptCode":"C14158","definition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE6DC488-B15F-8FD1-E040-BB89AD432EE0","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"47DDB57A-6702-08C0-E053-F662850AC0C1","beginDate":"2017-02-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-06","modifiedBy":"ONEDATA","dateModified":"2017-02-06","deletedIndicator":"No"},{"value":"2","valueDescription":"Intermediate Grade","ValueMeaning":{"publicId":"3335158","version":"1","preferredName":"Intermediate Grade","longName":"3335158","preferredDefinition":"A term referring to the degree of differentiation of a malignant neoplasm and indicating that it is moderately differentiated.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intermediate Grade","conceptCode":"C28083","definition":"A term referring to the degree of differentiation of a malignant neoplasm and indicating that it is moderately differentiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B43D00DA-4E4B-7AC2-E040-BB89AD434B8C","latestVersionIndicator":"Yes","beginDate":"2011-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"47DDB57A-6716-08C0-E053-F662850AC0C1","beginDate":"2017-02-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-06","modifiedBy":"ONEDATA","dateModified":"2017-02-06","deletedIndicator":"No"},{"value":"1","valueDescription":"Low Grade","ValueMeaning":{"publicId":"3288210","version":"1","preferredName":"Low Grade","longName":"3288210","preferredDefinition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade","conceptCode":"C14161","definition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE6DC488-B13C-8FD1-E040-BB89AD432EE0","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"47DDB57A-6720-08C0-E053-F662850AC0C1","beginDate":"2017-02-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-06","modifiedBy":"ONEDATA","dateModified":"2017-02-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5654311","version":"1","preferredName":"Neoplasm Histologic Grade Code","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.:A symbol or combination of symbols which is assigned to the members of a collection.","longName":"C3262:C18000:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"47DDB57A-66D7-08C0-E053-F662850AC0C1","latestVersionIndicator":"Yes","beginDate":"2017-02-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-06","modifiedBy":"ONEDATA","dateModified":"2017-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FB53D1B-7F0D-60BD-E053-F662850A5B35","latestVersionIndicator":"Yes","beginDate":"2016-10-25","endDate":null,"createdBy":"UMLLOADER_EDRN","dateCreated":"2016-10-25","modifiedBy":"KNABLEJ","dateModified":"2021-06-24","changeDescription":"6/24/21 jk released for reuse by HTAN, Biospecimen tier 2.  2/6/17 Modified VD per ws. AK","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5542681","version":"1","longName":"EDRN_CDE_Project","context":"EDRN","ClassificationSchemeItems":[{"publicId":"5542682","version":"1","longName":"Biospecimen CDEs","context":"EDRN"},{"publicId":"10000601","version":"1","longName":"EDRN-CDEs","context":"EDRN"}]}],"AlternateNames":[{"name":"Ductal_Breast_Carcinoma_In_Situ:SPECIMEN_BREAST_DCISHISTGRADE_CODE_3380","type":"UML Class:UML Attr","context":"EDRN"},{"name":"EDRN-CDEs.Ductal_Breast_Carcinoma_In_Situ.SPECIMEN_BREAST_DCISHISTGRADE_CODE_3380","type":"UML Qualified Attr","context":"EDRN"}],"ReferenceDocuments":[{"name":"Histologic grade of DCIS (Van","type":"Preferred Question Text","description":"Histologic grade of DCIS (Van Nuy's Grading System):","url":null,"context":"EDRN"}],"origin":"EDRN:Early Detection Research Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FB556EF-5649-142D-E053-F662850AF4EF","latestVersionIndicator":"Yes","beginDate":"2016-10-25","endDate":null,"createdBy":"UMLLOADER_EDRN","dateCreated":"2016-10-25","modifiedBy":"KNABLEJ","dateModified":"2022-01-31","changeDescription":"1/31/22 jk Released per EDRN qtrly review/Brenda D; def and origin updated.  3/4/17 added Pref Question, updated long name. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}